Intelligent Bio Solutions Inc. (INBS) EPS (Basic) (2019 - 2025)
Intelligent Bio Solutions (INBS) posted quarterly EPS (Basic) of -$5.81 for Q1 2025, up 67.63% year-over-year from -$3.47 in Q1 2024, and up 12.96% quarter-over-quarter from -$6.68 in Q4 2024.
Intelligent Bio Solutions Inc. (INBS) EPS (Basic) (2019 - 2025) Analysis & Trends
Intelligent Bio Solutions' EPS (Basic) history runs 7 years deep, the most recent figure standing at -$5.81 for Q1 2025.
- In Q1 2025, EPS (Basic) rose 67.63% year-over-year to -$5.81; the TTM figure through Jun 2025 stood at -$18.76 (up 87.03% YoY), while the FY2024 annual figure was -$129.99, up 95.08% from the prior year.
- EPS (Basic) for Q1 2025 stood at -$5.81, up from -$6.68 in the prior quarter.
- The five-year high for EPS (Basic) was $1648.6 in Q2 2021, with the low at -$1461.4 in Q2 2023.
- The 5-year median for EPS (Basic) is -$216.66 (2022), against an average of -$416.42.
- Peak annual rise in EPS (Basic) reached 270.16% in 2021, while the deepest fall reached 3738.62% in 2021.
- Intelligent Bio Solutions' EPS (Basic) stood at -$558.59 in 2021, then sank by 143.12% to -$1358.0 in 2022, then surged by 97.84% to -$29.34 in 2023, then soared by 77.24% to -$6.68 in 2024, then rose by 12.96% to -$5.81 in 2025.
- Business Quant data shows INBS's EPS (Basic) at -$5.81 in Q1 2025, -$6.68 in Q4 2024, and -$9.21 in Q3 2024.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | -5.81 |
| Dec 31, 2024 | -6.68 |
| Sep 30, 2024 | -9.21 |
| Jun 30, 2024 | -83.08 |
| Mar 31, 2024 | -17.95 |
| Dec 31, 2023 | -29.34 |
| Sep 30, 2023 | -169.50 |
| Jun 30, 2023 | -1,461.37 |
| Mar 31, 2023 | -687.52 |
| Dec 31, 2022 | -1,358.05 |
| Sep 30, 2022 | -1,214.76 |
| Jun 30, 2022 | -1,333.66 |
| Mar 31, 2022 | -216.66 |
| Dec 31, 2021 | -558.59 |
| Sep 30, 2021 | -246.37 |
| Jun 30, 2021 | 1,648.55 |
| Mar 31, 2021 | -1,329.10 |
| Dec 31, 2020 | -1,098.50 |
| Sep 30, 2020 | -299.48 |
| Jun 30, 2020 | 445.36 |